SLU-PP-332 vs MOTS-C: Research Comparison and Sourcing Guide

SLU-PP-332 and MOTS-C target metabolic and cellular pathways through fundamentally different mechanisms: SLU-PP-332 acts as a synthetic estrogen-related receptor (ERR) agonist, while MOTS-C is a mitochondrial-derived peptide regulating nuclear gene expression and AMPK activation. PX1 Research supplies high-purity reference standards for both compounds, manufactured via USA synthesis, backed by lot-specific HPLC/MS and endotoxin testing, and dispatched same-day M–F from CA and AZ.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

SLU-PP-332 and MOTS-C target metabolic and cellular pathways through fundamentally different mechanisms: SLU-PP-332 acts as a synthetic estrogen-related receptor (ERR) agonist, while MOTS-C is a mitochondrial-derived peptide regulating nuclear gene expression and AMPK activation. PX1 Research supplies high-purity reference standards for both compounds, manufactured via USA synthesis, backed by lot-specific HPLC/MS and endotoxin testing, and dispatched same-day M–F from CA and AZ.

Reviewed by PX1 Research scientific team

Key takeaways

  • While both compounds are actively investigated for mitochondrial function, metabolic regulation, and exercise-capacity research, their molecular architecture and target receptors differ significantly.
  • SLU-PP-332 is a non-steroidal synthetic agonist that targets the estrogen-related receptor family, specifically exhibiting potent activity at ERRα, ERRβ, and ERRγ.
  • [MOTS-C](/research-peptides/mots-c) (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) represents a distinct class of signaling molecules known as mitochondrial-derived peptides (MDPs).
  • When designing comparative in vitro or animal model protocols, researchers must evaluate several key structural and functional parameters to select the appropriate compound for their specific experimental model.

Quick answer: SLU-PP-332 vs MOTS-C at a glance

While both compounds are actively investigated for mitochondrial function, metabolic regulation, and exercise-capacity research, their molecular architecture and target receptors differ significantly. SLU-PP-332 is a synthetic small-molecule ERR agonist designed to stimulate nuclear estrogen-related receptors (ERRα, ERRβ, and ERRγ), inducing a transcriptional cascade that mimics exercise-induced oxidative metabolism. In contrast, MOTS-C is a naturally occurring 16-amino-acid peptide encoded by the mitochondrial genome that translocates to the nucleus under metabolic stress to alter gene expression and activate AMPK pathways.

Researchers seeking to evaluate direct transcriptional induction of oxidative muscle fiber phenotypes typically prioritize SLU-PP-332 research, whereas laboratories focusing on mitochondrial-nuclear communication, systemic insulin sensitivity, and age-related metabolic homeostasis frequently select MOTS-C research protocols. Both research tools can be sourced directly through the PX1 Research catalog with complete analytical verification.

What is SLU-PP-332? ERR receptor activation mechanisms

SLU-PP-332 is a non-steroidal synthetic agonist that targets the estrogen-related receptor family, specifically exhibiting potent activity at ERRα, ERRβ, and ERRγ. These orphan nuclear receptors serve as primary transcriptional regulators of mitochondrial biogenesis, oxidative phosphorylation, and fatty acid beta-oxidation in high-demand metabolic tissues such as skeletal muscle, heart, and liver.

Preclinical mouse models demonstrate that activation of ERR receptors by SLU-PP-332 increases energy expenditure, elevates oxidative slow-twitch muscle fiber composition, and enhances basal metabolic rate without requiring prior physical conditioning. Because it acts directly on nuclear receptors rather than signaling through membrane receptors, SLU-PP-332 provides an isolated model for studying receptor-mediated genomic responses in metabolic and endurance research. Laboratories can explore physical specifications and analytical documentation for this compound on the SLU-PP-332 product page.

What is MOTS-C? Mitochondrial-derived peptide signaling

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) represents a distinct class of signaling molecules known as mitochondrial-derived peptides (MDPs). Encoded within the mitochondrial DNA rather than the nuclear genome, MOTS-C acts as a metabolic hormone that mediates adaptive stress responses across cellular compartments.

Under cellular metabolic stress, MOTS-C translocates from the mitochondrion to the cell nucleus, where it interacts with transcription factors such as NRF2 to regulate antioxidant defenses and carbohydrate metabolism. Concurrently, MOTS-C activates 5'-AMP-activated protein kinase (AMPK), promoting glucose uptake and fatty acid oxidation independently of classical insulin receptor pathways. Researchers evaluating metabolic regulation and mitochondrial stress responses can review reference material on the MOTS-C product page.

Head-to-head criteria comparison: SLU-PP-332 vs MOTS-C

When designing comparative in vitro or animal model protocols, researchers must evaluate several key structural and functional parameters to select the appropriate compound for their specific experimental model.

• Receptor Target and Mechanism: SLU-PP-332 acts as a direct nuclear receptor agonist (ERRα/β/γ), driving transcriptional programs for oxidative phosphorylation. MOTS-C acts via nuclear translocation and AMPK phosphorylation, serving as an endogenous retro-hormone. • Molecular Class: SLU-PP-332 is a synthetic organic small-molecule pan-ERR agonist. MOTS-C is a 16-amino-acid peptide (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-NH2) derived from mitochondrial 12S rRNA. • Preclinical Evidence Base: SLU-PP-332 is documented in high-fat diet rodent models to enhance running endurance, decrease fat mass accumulation, and increase oxidative gene expression. MOTS-C is extensively studied in aged mouse models for insulin resistance attenuation, exercise capacity expansion, and cellular longevity signaling. • Available Formats: SLU-PP-332 is available in stable reference capsules and raw powder formulations. MOTS-C is supplied as a lyophilized peptide powder requiring cold-chain handling and reconstitution. • Handling and Stability: SLU-PP-332 exhibits superior chemical stability at room temperature in solid state. Lyophilized MOTS-C requires storage at -20°C and reconstitutes in sterile bacteriostatic water for immediate laboratory use. • Typical Study Focus: SLU-PP-332 is selected for direct exercise-mimetic transcription research and lipid oxidation assays. MOTS-C is preferred for inter-organellar signaling studies, age-related metabolic decay assays, and glucose transporter mobilization research.

Mechanistic pathways: ERR signaling versus AMPK activation

To understand the distinct biochemical utility of these two agents, researchers must analyze their downstream signaling pathways. SLU-PP-332 directly recruits coactivators such as PGC-1α to the ERR promoter elements. This binding upregulates genes encoding key enzymes in the tricarboxylic acid (TCA) cycle and electron transport chain complexes (Complex I–V), effectively rewiring cellular respiration toward elevated fatty acid consumption.

In contrast, MOTS-C regulates metabolic flux by targeting the folate cycle and purine biosynthesis pathways, leading to the accumulation of AICAR and subsequent phosphorylation of AMPK. Activated AMPK triggers downstream signaling that increases GLUT4 transporter translocation to cell membranes, enhancing glucose uptake independently of the insulin signaling cascade. For studies investigating broader mitochondrial repair or structural integrity, laboratories frequently cross-reference these models with SS-31 research protocols.

Preclinical evidence: Exercise capacity and metabolic regulation

In published rodent studies, both compounds demonstrate significant capacity to alter physiological parameters related to physical performance and metabolic homeostasis, though via different biological mechanisms.

Mice treated with SLU-PP-332 demonstrate a marked increase in running distance and time to exhaustion on treadmill assays without prior endurance training. Histological analyses show a shift in skeletal muscle fiber composition toward Type I (slow-twitch oxidative) fibers, accompanied by reduced body fat accumulation despite hypercaloric feeding. Conversely, MOTS-C administration in aged mice prevents diet-induced obesity and age-dependent insulin resistance while improving physical performance parameters through systemic metabolic reprogramming. Researchers evaluating full metabolic panels can view related targets in the PX1 Research peptide library.

Laboratory handling, reconstitution, and storage protocols

Maintaining chemical integrity during laboratory assays requires strict adherence to handling standards based on the physical chemistry of each compound.

Lyophilized MOTS-C should be stored at -20°C upon receipt. Prior to reconstitution, vials must be brought to room temperature to prevent condensation. Reconstitution should be performed using sterile bacteriostatic water or target-appropriate assay buffers, avoiding aggressive vortexing to preserve peptide tertiary structure. Reconstituted solutions remain stable at 4°C for short-term benchwork or -80°C for long-term storage.

SLU-PP-332 small-molecule reference material exhibits high structural stability under ambient conditions. However, stock solutions prepared in DMSO or organic solvents should be aliquoted, protected from light exposure, and stored at -20°C to prevent degradation over extended study timelines.

How to vet a research supplier for mitochondrial compounds

Securing high-purity, standardized compounds is essential for reproducibility in metabolic and mitochondrial research. Substandard reference reagents introduce confounding variables that compromise assay integrity and yield invalid experimental data. Researchers should systematically verify suppliers against key quality benchmarks:

• Lot-Specific Analytics: Demand independent HPLC (High-Performance Liquid Chromatography) and MS (Mass Spectrometry) reports for the exact lot delivered, ensuring chemical identity and purity above 99%. • Endotoxin Quantification: Verify that peptide lots are tested via LAL (Limulus Amebocyte Lysate) assays to confirm endotoxin levels fall within acceptable limits (<0.01 EU/mg) for cell culture and animal models. • Synthesis Sourcing: Ensure compounds are synthesized in state-of-the-art facilities utilizing domestic quality management standards rather than re-packaged bulk imports. • Structural Integrity Verification: Confirm that small molecules like SLU-PP-332 and structural peptides like MOTS-C are stored in climate-controlled environments with moisture-barrier packaging.

Why source reference compounds from PX1 Research?

PX1 Research operates as a dedicated supplier of high-grade reference materials tailored specifically to institutional, academic, and private laboratory requirements. Every production lot undergoes rigorous analytical testing prior to release, guaranteeing that researchers receive uncompromised chemical standards.

By maintaining strict oversight of synthesis protocols, storage conditions, and rapid fulfillment workflows, PX1 Research removes supply-chain variance from critical research operations. Institutional buyers seeking bulk allocations or recurring lot reservations can review custom options on the PX1 Research wholesale portal.

Ordering from PX1 Research

When purchasing SLU-PP-332 capsules or MOTS-C lyophilized vials from PX1 Research, laboratory buyers receive fully characterized, lot-traceable reagents designed for immediate assay integration.

All orders placed before 3:00 PM EST (Monday through Friday) ship same-day from our fulfillment hubs in California and Arizona via tracked domestic carriers. Products are packaged in protective, temperature-shielded container systems accompanied by direct digital access to lot-specific Certificates of Analysis (COAs). Our technical support staff remains accessible to assist lab managers with analytical documentation, bulk logistics, and specification inquiries. Explore our full catalog to place your order through the PX1 Research product catalog.

Frequently Asked Questions

What is the primary mechanistic difference between SLU-PP-332 and MOTS-C?

SLU-PP-332 is a synthetic small-molecule agonist targeting nuclear estrogen-related receptors (ERRα/β/γ) to directly induce oxidative gene expression. MOTS-C is a mitochondrial-derived peptide that translocates to the nucleus under stress, activating AMPK and regulating carbohydrate and lipid metabolism.

Is SLU-PP-332 legal to purchase for research in the US?

Yes, SLU-PP-332 is legal to purchase in the United States strictly for laboratory research, in vitro assays, and preclinical animal studies. It is not an FDA-approved drug or controlled substance, but it is prohibited for human consumption.

How fast does PX1 Research ship SLU-PP-332 and MOTS-C?

PX1 Research dispatches all orders placed before 3:00 PM EST, Monday through Friday, on the same business day. Orders ship via expedited, tracked domestic shipping from fulfillment centers in California and Arizona.

Do you provide a lot-specific COA for my order?

Yes, every batch of SLU-PP-332 and MOTS-C supplied by PX1 Research includes direct access to a lot-specific Certificate of Analysis. The COA provides full HPLC and Mass Spectrometry data along with endotoxin level testing.

What purity levels are guaranteed for PX1 Research compounds?

All reference peptides and small-molecule research compounds supplied by PX1 Research are verified at ≥99% purity by analytical High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).

Can SLU-PP-332 and MOTS-C be evaluated in the same study?

Yes, researchers frequently investigate SLU-PP-332 and MOTS-C in dual-arm or combination preclinical models to analyze potential synergy between direct ERR nuclear receptor activation and mitochondrial-derived AMPK signaling pathways.

How should MOTS-C be stored upon delivery to the lab?

Lyophilized MOTS-C powder should be stored immediately at -20°C in a dry, dark environment. Once reconstituted with sterile bacteriostatic water, liquid aliquots should be kept at 4°C for immediate short-term use or stored at -80°C.

Are SLU-PP-332 and MOTS-C approved for clinical human use?

No, neither SLU-PP-332 nor MOTS-C is approved by the FDA for clinical use, diagnosis, therapy, or human administration. They are strictly designated for preclinical laboratory research use only.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.